RLAY: Relay Therapeutics, Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 3 sales totaling $1.20M in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-07 | Patel Sanjiv | CEO | $872K | yes |
| 2026-10-06 | Catinazzo Thomas | CFO | $325K | yes |
| 2026-10-06 | Catinazzo Thomas | CFO | $4K | yes |
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-14 | 13G amendment | Commodore Capital LP | 5.50% | SEC | |
| 2026-08-10 | 13G amendment | Perceptive Advisors LLC | 6.40% | SEC | |
| 2026-08-07 | 13G stake raised | FMR LLC | 10.00% | +0.60 pts | SEC |
| 2026-08-06 | New 13G stake | FMR LLC | 9.40% | SEC |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.